BioSpace News Archive

Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular diseases

September 28, 2022
·
4 min read
Pharm Country

Verismo Therapeutics Receives U.S. FDA Orphan Drug Designation for SynKIR-110™, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma

Verismo Therapeutics, a clinical-stage CAR-T company and Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to SynKIR-110™ for the treatment of patients with mesothelin-expressing mesotheliomas.

September 28, 2022
·
3 min read
Policy

FDA Proposes Updated Definition of ‘Healthy’ Claim on Food Packages to Help Improve Diet, Reduce Chronic Disease

The U.S. Food and Drug Administration proposed updated criteria for when foods can be labeled with the nutrient content claim “healthy” on their packaging.

September 28, 2022
·
5 min read
Bio NC

IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc.

September 28, 2022
·
3 min read
Organ on a Chip Market Size Worth USD 209.4 Million in 2028 | Emergen Research

According to the most recent report by Emergen Research, the size of the worldwide organ on a chip market is anticipated to reach USD 209.4 Million in 2028, growing at a steady CAGR of 28.1%.

September 28, 2022
·
8 min read
Genetown

Molecular Loop Biosciences launches Monkeypox Research Sequencing Panels

Molecular Loop Biosciences, Inc., announced today that it has launched monkeypox targeting panels to support researchers conducting monkeypox viral surveillance and variant discovery.

September 28, 2022
·
2 min read
Business

ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO

ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Christopher Prentiss as Chief Financial Officer.

September 28, 2022
·
2 min read
Increase in Prevalence Rate of Psychotic Diseases, and Existing Genetic Predisposition are Expected to Drive Dyskinesia Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Dyskinesia Market – Forecast to 2030,’ thoroughly examines the Dyskinesia industry to provide essential data & information for the targeted readers

September 28, 2022
·
6 min read
Rising Demand for Medicines Related to the Treatment of Follicular Lymphoma is Expected to Drive Follicular Lymphoma Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Follicular Lymphoma Treatment Market – Forecast to 2030,’ thoroughly examines the Follicular Lymphoma Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
Rising Government Financing, and Unhealthy Lifestyle Choices are Expected to Drive Revenue Growth of Impaired Glucose Tolerance Treatment Market by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Impaired Glucose Tolerance Treatment Market – Forecast to 2030,’ thoroughly examines the Impaired Glucose Tolerance Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read